CDK1-IN-6

• Description:

  CDK1-IN-6 (Ligand 3) is a potent CDK1 inhibitor. CDK1-IN-6 has the potential for the research of cancer[1].

• UNSPSC:

  12352211

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk1-in-6.html

• Purity:

  99.96

• Smiles:

  CC1=CC=CC (NC2=CC (C3=CC=NC (N4CCOCC4) =C3) =CC=N2) =C1

• Molecular Formula:

  C21H22N4O

• Molecular Weight:

  346.43

• References & Citations:

  [1]Zuokun Lu, et al. Computational design of CDK1 inhibitors with enhanced target affinity and drug-likeness using deep-learning framework. Heliyon, 2024, 10 (22) .

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, stored under nitrogen, away from moisture)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CDK1